CN1524540A - Chinese medicine preparation for treating fatty liver and its preparation method - Google Patents
Chinese medicine preparation for treating fatty liver and its preparation method Download PDFInfo
- Publication number
- CN1524540A CN1524540A CNA031047483A CN03104748A CN1524540A CN 1524540 A CN1524540 A CN 1524540A CN A031047483 A CNA031047483 A CN A031047483A CN 03104748 A CN03104748 A CN 03104748A CN 1524540 A CN1524540 A CN 1524540A
- Authority
- CN
- China
- Prior art keywords
- radix
- fatty liver
- clear paste
- chinese medicine
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 15
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 15
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 15
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 title claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 229920002472 Starch Polymers 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 235000019698 starch Nutrition 0.000 claims abstract description 5
- 239000008107 starch Substances 0.000 claims abstract description 5
- 238000001291 vacuum drying Methods 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000011049 filling Methods 0.000 abstract 2
- 239000011505 plaster Substances 0.000 abstract 2
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 229930188824 alisol Natural products 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000009288 screen filtration Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese preparation for treating fatty liver and process for preparation, characterized by that, the constituent percentage by weight of the raw material are, alisol 12-30%, radix salvia miltiorrhiza 10-25%, haw 12-30%, cassia seed 10-25%, prepared fleece-flower root 5-20%, bupleurum root 5-20%. And the making process comprises the steps of, (1) extracting by ethanol backflow, (2) combination of extract, filtering, depression reclaiming, condensation into clear plaster, (3) watering and immersing, vacuum drying, (4) filling starch into plaster powder, blending, then filling ethanol to obtain the finished product. Clinical application of the invention has proved its substantial curative effect and no side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hepatopathy, particularly treat the Chinese medicine preparation and the manufacture method of fatty liver.
Background technology
Along with improving constantly of living standard, the sickness rate of fatty liver is also more and more higher, and the Chinese medicine medicine of treatment fatty liver is generally selected the Radix Salviae Miltiorrhizae blood fat reducing for use, and single Radix Salviae Miltiorrhizae blood fat reducing therapeutic effect is not remarkable, the relapse rate height.Prevent the Chinese medicine compound medicine that does not also have at present to treat fatty liver merely to occur.
Summary of the invention
The object of the present invention is to provide and a kind ofly form, the Chinese medicine preparation and the manufacture method of the treatment fatty liver of manufacturing according to certain production technology by six kinds of raw material of Chinese medicine.
The object of the present invention is achieved like this: its raw material and weight percent content are Rhizoma Alismatis 12-30%, Radix Salviae Miltiorrhizae 10-25%, Fructus Crataegi 12-30%, Semen Cassiae 10-25%, Radix Polygoni Multiflori Preparata 5-20%, Radix Bupleuri 5-20%.
Its manufacture method is undertaken by following step,
A, Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi are added the alcohol reflux 2 times that concentration is 60-80%, each 2 hours respectively at first in proportion;
B, the extracting solution of Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi is merged, filter, decompression recycling ethanol is condensed into the clear paste of certain relative density when not having the alcohol flavor, and clear paste is standby;
C, the medicinal residues after Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi filtered were soaked 2 hours with the Semen Cassiae, Radix Polygoni Multiflori Preparata, the Radix Bupleuri that take by weighing in proportion, and soak the back and decoct twice, collecting decoction, and with its filtration, filtrate for later use;
D, will be concentrated into the clear paste of certain relative density the merging of above-mentioned clear paste and filtrate, with the clear paste vacuum drying, it is standby to become dry extract;
Add starch in e, the past cream powder, mixing adds an amount of general ball of ethanol then, makes finished product.
The pharmacological action of various medicines of the present invention is: Rhizoma Alismatis has diuresis, the function of clearing away damp-heat.Be used for dysuria, edema distension, the oliguria of having loose bowels, dizziness due to fluid-retention, the puckery pain of pyretic stranguria, hyperlipidemia.The Radix Salviae Miltiorrhizae stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire.Be used for menoxenia, the amenorrhea amenorrhea, sick abdominal mass is gathered, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia, hepatosplenomegaly, angina pectoris.Hawthorn digesting is built stomach, the circulation of qi promoting dissipating blood stasis.Be used for meat stagnation, gastralgia, dysentery stomachache, blood stasis amenorrhea, hernia pain, hyperlipemia.The Radix Bupleuri reconciling superficies and interior, soothing the liver yang invigorating.Be used for cold, fever, alternate attack of chill and fever, sternal rib pain, menoxenia, uterine prolapse, proctoptosis.The Semen Cassiae clearing away heat to improve acuity of vision, loosening bowel to relieve constipation.Be used for the puckery pain of conjunctival congestion, the many tears of photophobia, it is dizzy to have a headache, poor vision, constipation.The Radix Polygoni Multiflori Preparata invigorating the liver and kidney, benefiting essence-blood, black beard and hair bone and muscle strengthening.Be used for blood deficiency and yellow complexion, vertigo and tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, chronic malaria body void, hyperlipemia.
The present invention proves through clinical use, is raw material with the said medicine, and through the Chinese medicine preparation that the processing technique of exquisiteness makes, therapeutic effect is remarkable, has no side effect.Its raw material is easy to get, and production technology is simple, processing ease.Especially take the present invention and can effect a radical cure fatty liver up hill and dale, accelerate metabolism, relapse rate is almost nil.
The specific embodiment
The weight percent content embodiment such as the following table of raw material of the present invention:
Table 1
| Material name | Weight percent content (%) | |||||
| Rhizoma Alismatis | 15 | ?20 | ?25 | ?12 | 30 | ?18 |
| Radix Salviae Miltiorrhizae | 10 | ?20 | ?25 | ?15 | ?18 | ?10 |
| Fructus Crataegi | 20 | ?20 | ?12 | ?23 | ?15 | ?30 |
| Semen Cassiae | 15 | ?25 | ?10 | ?20 | ?22 | ?18 |
| Radix Polygoni Multiflori Preparata | 20 | ?5 | ?18 | ?15 | ?10 | ?12 |
| Radix Bupleuri | 20 | ?10 | ?10 | ?15 | ?5 | ?12 |
| Add up to | 100 | ?100 | ?100 | ?100 | ?100 | ?100 |
Manufacture method embodiment of the present invention:
1, take by weighing Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi according to the above ratio, respectively with Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi, the ethanol that adds concentration and be 60-85% was multi-function extractor internal reflux 2 times, each 2 hours.
2, then the reflux extracting liquid of three kinds of medicines is combined, with 60 purpose screen filtrations, filtered liquid medicine is put into ethanol recycling can reduced-pressure backflow do not end to there being the alcohol flavor, putting into vacuum concentration pot then, to be condensed into relative density be that the clear paste of 0.8-1.5 is standby.
3, the medicinal residues after Rhizoma Alismatis, Radix Salviae Miltiorrhizae, the Fructus Crataegi filtration and the Semen Cassiae that takes by weighing in proportion, Radix Polygoni Multiflori Preparata, Radix Bupleuri mixing and water adding (every 1kg adds water 8kg) were soaked 2 hours, soak 2 hours after-filtration of back decoction, filtrate for later use.And then decoct with water medicinal residues and the Semen Cassiae, Radix Polygoni Multiflori Preparata, the Radix Bupleuri that take by weighing in proportion 1.5 hours after Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi are filtered, and decocting liquid is filtered filtrate for later use; The filtrate of twice decoction is merged, filter filtrate for later use once more.
4, above-mentioned clear paste and filtrate merging are concentrated into the clear paste that relative density is 08-15, the clear paste of relative density is put into the spray dryer vacuum drying, it is standby to become dry extract;
5, add starch in the cream powder, the fine powder of every 42g adds starch 8g, and it is the ethanol of 60-85% that mixed evenly back adds concentration, the per kilogram mixing fine powders adds the general ball of an amount of ethanol, and the addition of the general ball of ethanol is stared at according to the character of season and cream powder, if cream powder tide, then add less, on the contrary also anti-.Make the pack of finished product solid preparation, every bag 5 gram.
Instructions of taking of the present invention: oral every day three times, each 5 grams.
The present invention has used for many years clinically as the preparation of treatment fatty liver and hyperlipidemia, and curative effect is preferably arranged.Clinical observation obese fatty liver 30 examples, 3 months courses of treatment, the result shows that total obvious effective rate is 70%, total effective rate 93.3%.To stopping in the turbid damp, total obvious effective rate of stagnation of liver-QI Blood stasis is 73.5%, and total effective rate is 96.7%.The present invention can obviously improve the patient to be coerced costalgia and expands, distension and fullness in the abdomen, and inappetence, the cardinal symptom signs such as not well and hepatomegaly of defecating are improved effect comparatively significantly to unusually also having of blood fat ACT.Do not find obvious adverse reaction in the observation process.
Claims (4)
1, a kind of Chinese medicine preparation for the treatment of fatty liver is characterized in that, its raw material and weight percent content are Rhizoma Alismatis 12-30%, Radix Salviae Miltiorrhizae 10-25%, Fructus Crataegi 12-30%, Semen Cassiae 10-25%, Radix Polygoni Multiflori Preparata 5-20%, Radix Bupleuri 5-20%.
2 one kinds of manufacture methods for the treatment of the Chinese medicine preparation of fatty liver is characterized in that it is undertaken by following step,
A, Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi are added the alcohol reflux 2 times that concentration is 60-80%, each 2 hours respectively at first in proportion;
B, the extracting solution of Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi is merged, filter, decompression recycling ethanol is condensed into the clear paste of certain relative density when not having the alcohol flavor, and clear paste is standby;
C, the medicinal residues after Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi filtered were soaked 2 hours with the Semen Cassiae, Radix Polygoni Multiflori Preparata, the Radix Bupleuri that take by weighing in proportion, and soak the back and decoct twice, collecting decoction, and with its filtration, filtrate for later use;
D, will be concentrated into the clear paste of certain relative density the merging of above-mentioned clear paste and filtrate, with the clear paste vacuum drying, it is standby to become dry extract;
Add starch in e, the past cream powder, mixing adds an amount of general ball of ethanol then, makes finished product.
3, the manufacture method of the Chinese medicine preparation of treatment fatty liver according to claim 2, it is characterized in that, medicinal residues after Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Fructus Crataegi are filtered are soaked the back with the Semen Cassiae, Radix Polygoni Multiflori Preparata, the Radix Bupleuri that take by weighing in proportion and were decocted 2 hours for the first time, decoct 1.5 hours for the second time.
4, the Chinese medicine preparation of treatment fatty liver according to claim 1 and 2 and manufacture method, the relative density that it is characterized in that described clear paste is 0.8-1.5, general ball concentration of ethanol is 70-90%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03104748 CN1220506C (en) | 2003-02-28 | 2003-02-28 | Chinese medicine preparation for treating fatty liver and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03104748 CN1220506C (en) | 2003-02-28 | 2003-02-28 | Chinese medicine preparation for treating fatty liver and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1524540A true CN1524540A (en) | 2004-09-01 |
| CN1220506C CN1220506C (en) | 2005-09-28 |
Family
ID=34239169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03104748 Expired - Fee Related CN1220506C (en) | 2003-02-28 | 2003-02-28 | Chinese medicine preparation for treating fatty liver and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1220506C (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1566169A1 (en) * | 2004-02-10 | 2005-08-24 | ABOCA S.p.A. | Cosmetic compositions containing combinations of Bupleurum species extracts and Salvia miltiorrhiza extracts for the treatment and reduction of blemishes caused by cellulite |
| CN1299733C (en) * | 2005-03-15 | 2007-02-14 | 青岛浩普医药研究有限公司 | Chinese medicine and its preparing method and use |
| CN1299715C (en) * | 2004-12-31 | 2007-02-14 | 闫自力 | Preparing tablets of reducing blood fat |
| CN1313113C (en) * | 2005-07-13 | 2007-05-02 | 张惠云 | 'Wudan Xinggan' granular for treating fatty liver, and its prepn. method |
| CN1330346C (en) * | 2005-05-22 | 2007-08-08 | 崔秀芝 | Chinese proprietary medicine for treating hypertension and hyperlipemia and preparation process thereof |
| CN100393334C (en) * | 2006-04-26 | 2008-06-11 | 闫聿逊 | A method for preparing fat-reducing medicine |
| CN102106992A (en) * | 2011-01-30 | 2011-06-29 | 河南中医学院 | Chinese medicinal granules for treating non-alcoholic steatohepatitis |
| CN102125676A (en) * | 2010-10-27 | 2011-07-20 | 宋爱民 | Traditional Chinese medicine preparation for treating fatty liver |
| CN102488798A (en) * | 2011-12-13 | 2012-06-13 | 广州中医药大学 | Medicine for treating non-alcoholic fatty liver |
| CN103230486A (en) * | 2013-04-17 | 2013-08-07 | 苏州深久医药生物技术有限公司 | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver |
| CN103301267A (en) * | 2013-07-07 | 2013-09-18 | 崔新明 | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof |
| CN103989995A (en) * | 2014-05-22 | 2014-08-20 | 李晓杰 | Pharmaceutical composition for treating fatty liver |
| CN104189631A (en) * | 2014-07-28 | 2014-12-10 | 王永远 | Traditional Chinese medicine composition with effect of reducing weight and lowering lipid and preparation method thereof |
| CN109620937A (en) * | 2019-02-20 | 2019-04-16 | 江西省人民医院 | A kind of rouge that disappears answers the drug and preparation method of liver |
-
2003
- 2003-02-28 CN CN 03104748 patent/CN1220506C/en not_active Expired - Fee Related
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1566169A1 (en) * | 2004-02-10 | 2005-08-24 | ABOCA S.p.A. | Cosmetic compositions containing combinations of Bupleurum species extracts and Salvia miltiorrhiza extracts for the treatment and reduction of blemishes caused by cellulite |
| CN1299715C (en) * | 2004-12-31 | 2007-02-14 | 闫自力 | Preparing tablets of reducing blood fat |
| CN1299733C (en) * | 2005-03-15 | 2007-02-14 | 青岛浩普医药研究有限公司 | Chinese medicine and its preparing method and use |
| CN1330346C (en) * | 2005-05-22 | 2007-08-08 | 崔秀芝 | Chinese proprietary medicine for treating hypertension and hyperlipemia and preparation process thereof |
| CN1313113C (en) * | 2005-07-13 | 2007-05-02 | 张惠云 | 'Wudan Xinggan' granular for treating fatty liver, and its prepn. method |
| CN100393334C (en) * | 2006-04-26 | 2008-06-11 | 闫聿逊 | A method for preparing fat-reducing medicine |
| CN102125676B (en) * | 2010-10-27 | 2012-05-30 | 宋爱民 | Traditional Chinese medicine preparation for treating fatty liver |
| CN102125676A (en) * | 2010-10-27 | 2011-07-20 | 宋爱民 | Traditional Chinese medicine preparation for treating fatty liver |
| CN102106992A (en) * | 2011-01-30 | 2011-06-29 | 河南中医学院 | Chinese medicinal granules for treating non-alcoholic steatohepatitis |
| CN102106992B (en) * | 2011-01-30 | 2012-06-06 | 河南中医学院 | Chinese medicinal granules for treating non-alcoholic steatohepatitis |
| CN102488798A (en) * | 2011-12-13 | 2012-06-13 | 广州中医药大学 | Medicine for treating non-alcoholic fatty liver |
| CN102488798B (en) * | 2011-12-13 | 2014-03-05 | 广州中医药大学 | Medicine for treating non-alcoholic fatty liver |
| CN103230486A (en) * | 2013-04-17 | 2013-08-07 | 苏州深久医药生物技术有限公司 | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver |
| CN103230486B (en) * | 2013-04-17 | 2014-11-05 | 苏州深久医药生物技术有限公司 | Traditional Chinese medicine composition, preparation method thereof, and application thereof in preparing medicines used for treating fatty liver |
| CN103301267A (en) * | 2013-07-07 | 2013-09-18 | 崔新明 | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof |
| CN103301267B (en) * | 2013-07-07 | 2014-11-05 | 崔新明 | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof |
| CN103989995A (en) * | 2014-05-22 | 2014-08-20 | 李晓杰 | Pharmaceutical composition for treating fatty liver |
| CN104189631A (en) * | 2014-07-28 | 2014-12-10 | 王永远 | Traditional Chinese medicine composition with effect of reducing weight and lowering lipid and preparation method thereof |
| CN109620937A (en) * | 2019-02-20 | 2019-04-16 | 江西省人民医院 | A kind of rouge that disappears answers the drug and preparation method of liver |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1220506C (en) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1220506C (en) | Chinese medicine preparation for treating fatty liver and its preparation method | |
| CN1200281A (en) | Heatlh-care medicinal liquor | |
| CN108029821A (en) | Bark of eucommia solid health-care tea and preparation method thereof | |
| CN1141133C (en) | Chinese medicine for treating hypertension | |
| CN1123347C (en) | Chinese medicine for decreasing fat and lossing weight and preparation method thereof | |
| CN1211434A (en) | Oral liquid for resisting altitude stress and its preparation method | |
| CN110664940A (en) | Hair blackening pill and preparation method thereof | |
| CN1422636A (en) | Chinese medicine preparation for treating climacteric metancholia of women | |
| CN102416126A (en) | Chinese medicinal combination preparation for treating behcet syndrome and preparation method of Chinese medicinal combination preparation | |
| CN102895610A (en) | Medicine for treating edema | |
| CN101987188B (en) | Biological Chinese patent drug for preventing and treating hyperlipoidemia | |
| CN105477556A (en) | Medicine for treating myocardial infarction type coronary heart disease | |
| CN105497795A (en) | Medicine for treating coronary heart disease caused by stenocardia | |
| CN101683464A (en) | Chinese medicinal composition for tonifying kidney and promoting blood circulation | |
| CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
| CN104857121A (en) | Drug combination for curing hyperlipidemia and application thereof | |
| CN1943755A (en) | A Chinese traditional medicinal composition for treatment of hypertension and its preparation method | |
| CN105497338A (en) | Fallopia multiflora polygonum cuspidatum rhizome kidney tonifying and spleen invigorating hypolipidemic oral solution | |
| CN110575466A (en) | Composition for increasing bone mineral density and application thereof | |
| CN106074912A (en) | A kind of Chinese medicine preparation treating cardiovascular and cerebrovascular disease | |
| CN114712470B (en) | Medicine for treating deficiency of kidney of men and preparation method thereof | |
| CN102145119B (en) | Traditional Chinese medicinal composition for treating pulmonary heart diseases | |
| CN1136443A (en) | Medicine for defatting | |
| CN106166206A (en) | A kind of gynecological inflammation causes the rehabilitation medicine preparation method of frequent micturition | |
| CN105250671A (en) | Medicine for treating hyperlipoidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: TANGSHAN FULE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: TANGSHAN RONGDA PHARMACEUTICAL CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 063020 three Xin hi tech Industrial Park, Guye District, Hebei, Tangshan City Patentee after: Tangshan Fule Pharmaceutical Co.,Ltd. Address before: 063020 No. 24, Changning Road, North Tangshan City Road, Hebei Patentee before: TANGSHAN RONGDA PHARMACEUTICAL |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20160415 Granted publication date: 20050928 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20170415 Granted publication date: 20050928 |
|
| PD01 | Discharge of preservation of patent | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20170415 Granted publication date: 20050928 |
|
| PP01 | Preservation of patent right | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20211015 Granted publication date: 20050928 |
|
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20211015 Granted publication date: 20050928 |
|
| CI03 | Correction of invention patent |
Correction item: preservation of patent right and its discharge Correct: Cancellation of the cancellation of preservation on October 15, 2021 and the commencement of preservation False: 2021.10.15 release and commencement of preservation Number: 49-02 Volume: 37 |
|
| CI03 | Correction of invention patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20220415 Granted publication date: 20050928 |
|
| PD01 | Discharge of preservation of patent | ||
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20220507 Granted publication date: 20050928 |
|
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20230228 Granted publication date: 20050928 |
|
| PD01 | Discharge of preservation of patent | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050928 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |